Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
4
×
startups
4
×
boston blog main
life sciences
national blog main
national top stories
new york blog main
biotech
boston top stories
clinical trials
deals
detroit blog main
detroit top stories
healthcare
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
y combinator
abbvie
accelerator
adeno-associated virus
airbnb
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amazon web services (aws)
amunix
anirvan ghosh
artificial intelligence (a.i.)
What
years
4
×
ago
medicines
sciences
according
acquisitions
adding
admits
aiming
announced
attacks
balance
big
bio
bioscience
biotechs
build
cancer
ceo
classes
collabs
combinator
companies
counterpoint
covid
daniel
deal
decibel
diagnosis
died
disease
drugs
dug
emerged
focus
forms
gilead
gilead’s
globally
health
Language
unset
Current search:
cancer
×
startups
×
years
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@techcrunch.com
6 years ago
Tradewind Bioscience attacks the physiology of tumors to treat cancer
